The importance of doing HIV research in developing countries

L. Morris, D. J. Martin, Thomas C Quinn, Richard E Chaisson

Research output: Contribution to journalArticle

Abstract

Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?.

Original languageEnglish (US)
Pages (from-to)1228-1229
Number of pages2
JournalNature Medicine
Volume4
Issue number11
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Developing countries
Developing Countries
Biomedical Research
Patient Care
Acquired Immunodeficiency Syndrome
HIV
Research
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

The importance of doing HIV research in developing countries. / Morris, L.; Martin, D. J.; Quinn, Thomas C; Chaisson, Richard E.

In: Nature Medicine, Vol. 4, No. 11, 1998, p. 1228-1229.

Research output: Contribution to journalArticle

@article{acf4b177ce944b9a8ecac9f12faa4b5a,
title = "The importance of doing HIV research in developing countries",
abstract = "Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?.",
author = "L. Morris and Martin, {D. J.} and Quinn, {Thomas C} and Chaisson, {Richard E}",
year = "1998",
doi = "10.1038/3206",
language = "English (US)",
volume = "4",
pages = "1228--1229",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - The importance of doing HIV research in developing countries

AU - Morris, L.

AU - Martin, D. J.

AU - Quinn, Thomas C

AU - Chaisson, Richard E

PY - 1998

Y1 - 1998

N2 - Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?.

AB - Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?.

UR - http://www.scopus.com/inward/record.url?scp=0031730567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031730567&partnerID=8YFLogxK

U2 - 10.1038/3206

DO - 10.1038/3206

M3 - Article

C2 - 9809535

AN - SCOPUS:0031730567

VL - 4

SP - 1228

EP - 1229

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 11

ER -